selective oestrogen receptor degraders as treatment for er positive/her2 negative advanced/metas...
Published 4 years ago • 1.4K plays • Length 7:08Download video MP4
Download video MP3
Similar videos
-
4:39
serd vs investigator’s choice of endocrine monotherapy for er /her2-advanced/mbc
-
4:14
er degrader safe, with signs of antitumour activity against er-positive breast cancer
-
5:00
adjuvant endocrine therapy used to treat er her2- breast cancer
-
4:34
lasofoxifene vs fulvestrant for locally advanced/metastatic er /her2- breast cancer: elaine trial
-
30:44
what's new for the patient with er /her2- mbc progressing on cdk 4/6 inhibitor therapy? expert pe...
-
1:51
ameera-3: serd for er her2- breast cancer
-
6:55
mafalda oliveira, sabcs 2022: camizestrant vs fulvestrant for advanced er her2- breast cancer
-
2:46
rv-471: novel protac® estrogen receptor degrader, in er breast cancer
-
2:02:23
what i tell my patients: hormonal therapy for hormone receptor-positive breast cancer
-
1:15:47
evolving landscape of hr-positive metastatic breast cancer: a year in review
-
2:24
rad1901 for treatment of er breast cancer
-
20:37
gs2-02: "elacestrant, an oral selective estrogen receptor degrader (serd), vs investigator’s..."
-
5:03
hattersley: rad1901, a novel estrogen receptor degrader
-
1:02:48
expanding treatment options in er /her2- breast cancer: serds, serms, sercas, and more
-
0:50
op-1250: a small molecule oral complete estrogen receptor antagonist (ceran)
-
0:52
first-line camizestrant for er /her2- advanced breast cancer
-
1:13
what is hormone receptor positive (er /her2-) advanced breast cancer?
-
0:52
#therapy for breast cancer #cancer #breastcancer #fdaapproved drugs 2023 #orserdu#shorts
-
2:35
what does the future hold for serds in er breast cancer?